Affimed N.V. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
AFMD Nasdaq 2830 www.affimed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Affimed N.V.

Affimed to Present at the Cantor Global Healthcare Conference 2024 - Sep 10th, 2024 10:30 am
Affimed N.V.: Q2 Earnings Snapshot - Sep 5th, 2024 10:46 am
Affimed Reports Second Quarter 2024 Financial Results & Business Update - Sep 5th, 2024 10:30 am
Affimed Appoints New CEO, Shares Fall on Leadership Change - Sep 4th, 2024 3:26 pm
Affimed Appoints Shawn M. Leland as Chief Executive Officer - Sep 3rd, 2024 11:45 am
Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024 - Aug 29th, 2024 10:30 am
Oculis Holding AG (OCS) Reports Q2 Loss, Misses Revenue Estimates - Aug 27th, 2024 11:05 am
Affimed (AFMD) to Report Q2 Earnings: What's in the Cards? - Jul 29th, 2024 1:48 pm
Affimed N.V. (NASDAQ:AFMD) Upgraded by Laidlaw - Jun 14th, 2024 9:34 pm
Affimed N.V. (NASDAQ:AFMD) Q1 2024 Earnings Call Transcript - Jun 13th, 2024 12:02 pm
Affimed Reports First Quarter 2024 Financial Results & Business Update - Jun 12th, 2024 10:30 am
Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains? - Jun 7th, 2024 10:02 am
Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024 - Jun 5th, 2024 10:30 am
Affimed (AFMD) Soars on Upbeat Follow-Up Data From NSCLC Study - Jun 4th, 2024 3:32 pm
Is Affimed (AFMD) Outperforming Other Medical Stocks This Year? - Jun 4th, 2024 1:40 pm
Why Is German Biotech Affimed Stock Soaring On Monday? - Jun 3rd, 2024 8:13 pm
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort - Jun 1st, 2024 5:02 pm
Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer - May 29th, 2024 10:30 am
Affimed Announces Annual General Meeting of Shareholders - May 28th, 2024 10:30 am
7 Penny Biotech Stocks to Triple Your Investment - May 28th, 2024 10:10 am